Symbol
|
RMARSV | Z07YCZ | Z087QZ | RMAR2V |
---|---|---|---|---|
Nom | Autocallable Multi Defender Vonti | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti |
Sous-jacent
|
ABBVIE Inc. / Bristol-Myers Squibb Co. / Roche AG | ABBVIE Inc. / Eli Lilly & Co. / Merck & Co. Inc. | ABBVIE Inc. / Eli Lilly & Co. / Merck & Co. Inc. | Abbott Laboratories / ABBVIE Inc. / Eli Lilly & Co. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
Échéance
|
26.07.2024 | 31.07.2024 | 18.09.2024 | 15.12.2025 |
Demande | 61,20 | 104,59 | 103,85 | 100,80 |
Offre | 59,50 | 105,19 | 104,45 | 101,80 |